Status
Conditions
Treatments
About
This study is a follow-up extension study conducted in continuation of the prior MINT study (MMS-EEU-4), in which the long-term (i.e., 18, 24 months) clinical outcomes of Minimally Invasive Nasal Trabeculostomy (MINT) will be explored.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
36 participants in 1 patient group
Loading...
Central trial contact
Khan Lau, OD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal